EHU064651
MISSION® esiRNA
targeting human PARP16
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
NACRES:
NA.51
UNSPSC Code:
41105324
description
Powered by Eupheria Biotech
Quality Level
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
ATCTGCTGCTGCTGCTCATAGTGAGTGTCATCAACTCCTCTGCTTTCCAACACTTTTGGAATCGTGCGAAAAGATAATCTTTCTGGGCCTGGTGTGGGGGCTACCTCAACTATGTGCCTTATGGTAACTTGTTCTGTACCTCCTATGCCTCATGTCCAGCCAGGTTGAGCCTAGGGGCCAGTTGGGGGACCACAGGACAATTTTCATATGGCCTAAATGTATCCATTGCCTTTGATGATGTTCCCAGCCATACTCCAGTCAACGGGGACTACTAGTCCCTCACTCTTAGGTTTTAGGGGAGTCCTTCCATCTGCTCCTTCTTAAACTGTCCTAGGGAGTTGGCTTTTCAGCCAGGGCCAAAGGAAAAAGCCCTGCTGCATTTAAAAACAAAGTGTCCAAGCTGTCAGTGGTGTGT
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Gene Information
human ... PARP16(54956)
General description
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
Storage Class
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Haritha Kunhiraman et al.
Molecular and cellular biochemistry, 471(1-2), 15-27 (2020-05-31)
The biological activity of vascular endothelial growth factor (VEGF), the major cytokine regulating the process of angiogenesis is tightly controlled at multiple levels including processes involving post-translational modification such as ADP-ribosylation and glycosylation. ADP-ribosylation is a reversible NAD+-dependent modification, catalyzed
Global Trade Item Number
| SKU | GTIN |
|---|---|
| EHU064651-20UG | 04061828607365 |
| EHU064651-50UG | 04061828382316 |